Showing results (341-350 of 382) with videos related to
Sort By:
Pageof 39
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.Cancer Research|December 22, 2011
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapeSeng-Ryong Woo, Meghan E Turnis, Monica V Goldberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate CancerTomasz M Beer, Eugene D Kwon, Charles G Drake, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving NivolumabDavid F McDermott, Charles G Drake, Mario Sznol, et al.Scientific Reports|January 16, 2024
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinomaNirmish Singla, Thomas R Nirschl, Aleksandar Z Obradovic, et al.Cancer Immunology Research|February 23, 2018
Quantitative Analysis of Immune Infiltrates in Primary MelanomaRobyn D Gartrell, Douglas K Marks, Thomas D Hart, et al.Oncotarget|May 4, 2018
PD-L1 expression in medulloblastoma: an evaluation by subgroupAllison M Martin, Christopher J Nirschl, Magda J Polanczyk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 StudyEmmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2018
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and ImmunotherapyAriel E Marciscano, Ali Ghasemzadeh, Thomas R Nirschl, et al.Nature Cancer|February 5, 2022
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progressionZoila A Lopez-Bujanda, Michael C Haffner, Matthew G Chaimowitz, et al.Pageof 39